342 related articles for article (PubMed ID: 31509643)
1. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
[TBL] [Abstract][Full Text] [Related]
2. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of postreperfusion milieu determines acute kidney injury after liver transplantation: A prospective study.
Pulitano C; Ho P; Verran D; Sandroussi C; Joseph D; Bowen DG; McCaughan GW; Crawford M; Shackel N
Liver Transpl; 2018 Jul; 24(7):922-931. PubMed ID: 29684255
[TBL] [Abstract][Full Text] [Related]
5. Peri-transplant lactate levels and delayed lactate clearance as predictive factors for poor outcomes after liver transplantation: A propensity score-matched study.
Takahashi K; Jafri SR; Safwan M; Abouljoud MS; Nagai S
Clin Transplant; 2019 Jul; 33(7):e13613. PubMed ID: 31119814
[TBL] [Abstract][Full Text] [Related]
6. Onset of Donor Warm Ischemia Time in Donation After Circulatory Death Liver Transplantation: Hypotension or Hypoxia?
Kalisvaart M; de Haan JE; Polak WG; N M IJzermans J; Gommers D; Metselaar HJ; de Jonge J
Liver Transpl; 2018 Aug; 24(8):1001-1010. PubMed ID: 30142246
[TBL] [Abstract][Full Text] [Related]
7. Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation.
Fayed NA; Sayed EI; Saleh SM; Ehsan NA; Elfert AY
Clin Transplant; 2016 Apr; 30(4):470-82. PubMed ID: 26856320
[TBL] [Abstract][Full Text] [Related]
8. Impact of Temporary Portocaval Shunting and Initial Arterial Reperfusion in Orthotopic Liver Transplantation.
Pietersen LC; Sarton E; Alwayn I; Lam HD; Putter H; van Hoek B; Braat AE
Liver Transpl; 2019 Nov; 25(11):1690-1699. PubMed ID: 31276282
[TBL] [Abstract][Full Text] [Related]
9. Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury.
Zhang M; Nakamura K; Kageyama S; Lawal AO; Gong KW; Bhetraratana M; Fujii T; Sulaiman D; Hirao H; Bolisetty S; Kupiec-Weglinski JW; Araujo JA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282830
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 1 attenuates inflammation and hepatocellular damage in liver transplant ischemia/Reperfusion: From mouse to human.
Nakamura K; Kageyama S; Ke B; Fujii T; Sosa RA; Reed EF; Datta N; Zarrinpar A; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2017 Oct; 23(10):1282-1293. PubMed ID: 28719070
[TBL] [Abstract][Full Text] [Related]
11. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction.
Bastos-Neves D; Salvalaggio PRO; Almeida MD
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):423-429. PubMed ID: 30853253
[TBL] [Abstract][Full Text] [Related]
12. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.
Wadei HM; Lee DD; Croome KP; Mai ML; Golan E; Brotman R; Keaveny AP; Taner CB
Am J Transplant; 2016 Mar; 16(3):850-9. PubMed ID: 26663518
[TBL] [Abstract][Full Text] [Related]
13. Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.
Hirao H; Ito T; Kadono K; Kojima H; Naini BV; Nakamura K; Kageyama S; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Hepatology; 2021 Nov; 74(5):2759-2773. PubMed ID: 34170562
[TBL] [Abstract][Full Text] [Related]
14. Propofol intravenous anaesthesia with desflurane compared with desflurane alone on postoperative liver function after living-donor liver transplantation: A randomised controlled trial.
Shin S; Joo DJ; Kim MS; Bae MI; Heo E; Lee JS; Kim DW; Yoo YC
Eur J Anaesthesiol; 2019 Sep; 36(9):656-666. PubMed ID: 31083000
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 at reperfusion: A potent predictor of hepatic and extrahepatic early complications after liver transplantation.
Faitot F; Besch C; Lebas B; Addeo P; Ellero B; Woehl-Jaegle ML; Namer IJ; Bachellier P; Freys G
Clin Transplant; 2018 Sep; 32(9):e13357. PubMed ID: 30044000
[TBL] [Abstract][Full Text] [Related]
16. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
[TBL] [Abstract][Full Text] [Related]
17. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
Agopian VG; Markovic D; Klintmalm GB; Saracino G; Chapman WC; Vachharajani N; Florman SS; Tabrizian P; Haydel B; Nasralla D; Friend PJ; Boteon YL; Ploeg R; Harlander-Locke MP; Xia V; DiNorcia J; Kaldas FM; Yersiz H; Farmer DG; Busuttil RW
J Hepatol; 2021 Apr; 74(4):881-892. PubMed ID: 32976864
[TBL] [Abstract][Full Text] [Related]
18. Effect of liver transplants with retrograde reperfusion on early postoperative recovery of liver function and its risk factors.
Shen J; Wang M; Yang C; Cai Q; Jiang Y; Zhang X
BMC Surg; 2024 Jun; 24(1):174. PubMed ID: 38824553
[TBL] [Abstract][Full Text] [Related]
19. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort.
Croome KP; Lee DD; Perry DK; Burns JM; Nguyen JH; Keaveny AP; Taner CB
Liver Transpl; 2017 Mar; 23(3):342-351. PubMed ID: 28027600
[TBL] [Abstract][Full Text] [Related]
20. Liver graft preservation using perfluorocarbon improves the outcomes of simulated donation after cardiac death liver transplantation in rats.
Okumura S; Uemura T; Zhao X; Masano Y; Tsuruyama T; Fujimoto Y; Iida T; Yagi S; Bezinover D; Spiess B; Kaido T; Uemoto S
Liver Transpl; 2017 Sep; 23(9):1171-1185. PubMed ID: 28650112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
